Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Psilocybin program Recent news which mentions Psilocybin program < Previous 1 2 Next > Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute April 09, 2024 Tickers NEWS OPTHF Tags New Zealand Psychedelics Cannabis Market News From Benzinga Psilocybin Mushrooms For Sale: Is It Legal Anywhere In America? February 02, 2024 Tickers CMPS Tags Psilocybin program Benzinga psilocybin therapies From Benzinga Incannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In Australia December 22, 2023 Tickers IXHL NEWS Tags Markets Legal IXHL From Benzinga Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More December 11, 2023 Tickers ATAI BRAXF CMND CMPS Tags Psychedelics Reform News CMPS From Benzinga Alternative Treatment For Bipolar II Depression: Psilocybin Safe And Effective, AMA Study Finds December 06, 2023 Tickers CMPS Tags Psychedelics Health Care Small Cap From Benzinga Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More December 05, 2023 Tickers ATAI CMND CMPS CYBN Tags SILO PSIL Market News From Benzinga Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment November 24, 2023 Tags Psychedelics Cannabis Market News From Benzinga Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination November 16, 2023 Tickers NCAC Tags Legal Management M&A From Benzinga UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center November 15, 2023 Tickers AWKNF CMPS Tags News Ketamine/Assisted Therapy Legal From Benzinga Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market November 08, 2023 Tickers PMBHF Tags Psychedelic/Assisted Therapies Global Penny Stocks From Benzinga COMPASS Pathways Q3 2023 Results: Cash Injection To Sustain Phase 3 Psilocybin Program November 02, 2023 Tickers CMPS Tags Cannabis Markets Market News From Benzinga Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find November 01, 2023 Tickers CYBN Tags Psychedelics major depressive disorder Market News From Benzinga EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting October 26, 2023 Tags Benzinga Psilocybin program Psychedelic/Assisted Therapies From Benzinga EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy September 27, 2023 Tags Cannabis Market News Psilocybin program From Benzinga Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression September 21, 2023 Tickers CYBN DMTTF Tags major depressive disorder Psychedelics Market News From Benzinga Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here September 21, 2023 Tickers ENVB Tags Market News Markets Cannabis From Benzinga Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal September 20, 2023 Tags Politics Markets General From Benzinga Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More September 11, 2023 Tickers ATAI AWKNF CMND CMPS Tags MNMD ATAI HUGE From Benzinga Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More September 07, 2023 Tags Market News Cannabis Markets From Benzinga Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression September 06, 2023 Tickers CMPS Tags treatment/resistant depression Psychedelics Rumors From Benzinga Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows September 03, 2023 Tags Markets Guidance News From Benzinga Red Light Holland's Q1 2024 Performance: Revenue Soars 53% And Solid Cash Balance August 29, 2023 Tickers TRUFF Tags Guidance TRUFF Markets From Benzinga From Ice Rink To Healing Haven: Former NHL Player Sets Up Psilocybin Therapy Center In Colorado August 25, 2023 Tags News mental health Psychedelics From Benzinga Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors August 16, 2023 Tickers CMPS Tags Guidance Markets News From Benzinga Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing August 15, 2023 Tickers FLHLF JAQC Tags Psychedelics Contracts Psychedelic/Assisted Therapies From Benzinga Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs August 15, 2023 Tickers MYCOF Tags Market News Cannabis smoke cessation From Benzinga COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business' August 03, 2023 Tickers CMPS HTGC Tags Small Cap Psychedelics Market News From Benzinga Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 Tickers ATAI AWKNF CMPS CYBN Tags DMTTF ENVB Markets From Benzinga Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player August 01, 2023 Tickers MGCLF OPTHF TRUFF Tags Penny Stocks Psychedelic/Assisted Therapies Global From Benzinga Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer August 01, 2023 Tickers MYCOF Tags Psychedelics MYCOF Jamaica Psychedelics From Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.